Worth reading
60In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1150000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of the 39th Stock Acquisition Rights issued through a third-party allotment (with Exercise Price Adjustment Clause)
発行・処分する株式数
New shares 1,150,000 shares / Treasury shares 0 shares
Intended allottee
EVO FUND (allottee of the previously issued stock acquisition rights)
発行済株式総数
1.36% (exercise ratio subject to exercise restrictions)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Exercise prices during the subject month: ¥13.0, ¥16.0, ¥17.0, ¥20.0 and ¥23.0. Details of the adjustment provisions and the floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 600,000 units; exercised during the subject month: 11,500 units; unexercised at the end of the previous month: 261,500 units; unexercised at month-end: 250,000 units
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations
Most recent equity financing
Issued on 1 June 2026: 39th Series Stock Acquisition Rights (with an exercise price adjustment clause)
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 39th Stock Acquisition Rights issued through a third-party allotment (with Exercise Price Adjustment Clause) |
| Number of shares to be issued or disposed of | New shares 1,150,000 shares / Treasury shares 0 shares |
| Intended allottee | EVO FUND (allottee of the previously issued stock acquisition rights) |
| Dilution Rate | 1.36% (exercise ratio subject to exercise restrictions) |
| Total number of issued shares | 118,488,408 shares (as of the end of the month preceding the subject month) → Not disclosed |
| Exercise price | Exercise prices during the subject month: ¥13.0, ¥16.0, ¥17.0, ¥20.0 and ¥23.0. Details of the adjustment provisions and the floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 600,000 units; exercised during the subject month: 11,500 units; unexercised at the end of the previous month: 261,500 units; unexercised at month-end: 250,000 units |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with the exercise restrictions under Article 434 of the Listing Regulations |
| Most recent equity financing | Issued on 1 June 2026: 39th Series Stock Acquisition Rights (with an exercise price adjustment clause) |
Items this document does not state (19)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the exercise status for October 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.